Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 23, Issue 1, 2000, Pages 44-51

  Wasmuth, Jan Christian ^a   Klein, Karl H ^b   Hackbarth, Frank ^b   Rockstroh, Jürgen K ^b   Sauerbruch, Tilman ^b   Spengler, Ulrich ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

Apoptosis; CD4+ T cell counts; Flow cytometry; Prognosis; Progression

Indexed keywords

ANNEXIN; BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

ACCURACY; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; T LYMPHOCYTE; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034051732     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200001010-00006     Document Type: Article

References (32)

1. Baier Bitterlich G, Wachter H, Fuchs D. Role of neopterin and 7,8-dihydroneopterin in human immunodeficiency virus infection: marker for disease progression and pathogenic link. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:184-93.
2. Ashton LJ, Carr A, Cunningham PH, et al. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group [in process citation]. AIDS Res Hum Retroviruses 1998;14:117-21.
3. Stein DS, Lyles RH, Graham NM, et al. Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study. J Infect Dis 1997;176:1161-7.
4. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:83-92.
5. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991;12: 102-5.
6. Oyaizu N, Pahwa S. Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 1995;15:217-31.
7. Famularo G, De Simone C, Marcellini S. Apoptosis: mechanisms and relation to AIDS. Med Hypotheses 1997;48:423-9.
8. Carbonari M, Cibati M, Cherchi M, et al. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994;83:1268-77.
9. Uren AG, Vaux DL. Molecular and clinical aspects of apoptosis. Pharmacol Ther 1996;72:37-50.
10. + T lymphocytes and preferential loss of memory cells on interaction of mononuclear cells with HIV-1 glycoprotein-expressing cells. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:74-82.
11. Ferlini C, Kunkl A, Scambia G, Fattorossi A. The use of Apostain in identifying early apoptosis. J Immunol Methods 1997;205:95-101.
12. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
14. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
15. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
16. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
17. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992;90:376-82.
18. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996;156:3509-20.
19. Prati E, Gorla R, Malacarne F, et al. Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res Hum Retroviruses 1997;13:1501-8.
20. + cells during human immunodeficiency virus type 1 infection - correlation with clinical progression, viral load, and loss of humoral immunity. Virology 1997;238: 180-8.
21. MacLennan IC, Gulbranson Judge A, Toellner KM, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev 1997;156:53-66.
22. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [see comments]. Nature 1995;373:123-6.
23. Rothen M, Gratzl S, Hirsch HH, Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res Hum Retroviruses 1997;13:771-9.
24. Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 1986;29:307-35.
25. Johnson N, Parkin JM. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 1998;113:229-34.
26. + T cells from HIV-infected patients increases with disease progression. J Mol Med 1995;73:591-3.
27. McCloskey TW, Oyaizu N, Kaplan M, Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 1995;22:111-4.
28. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996;10:9-16.
29. + T lymphocytes is not mediated by Fas-Fas ligand. AIDS 1997;11:1671-80.
30. + T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF Receptor 1. J Immunol 1997;159:5246-52.
31. Campion JP, Porchet N, Aubert JP, L'Helgoualc'h A, Clement B. UW-presentation of cultured gallbladder epithelial cells: phenotypic alterations and differential mucin gene expression in the presence of bile. Hepatology 1995;21:223-31.
32. Wilhelm S, Wagner H, Hacker G. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur J Immunol 1998;28:891-900.